Clinical Trials Directory

Trials / Completed

CompletedNCT06522399

Outcome of TAMIS Mucosal Resection in Patients With ODS

Outcome of Transanal Minimally Invasive (TAMIS) Mucosal Resection in Patients With Obstructed Defecation Syndrome - a Pilot Study

Status
Completed
Phase
Study type
Observational
Enrollment
11 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Patients, aged 18 - 90 years, undergoing TAMIS mucosectomy at the Department of General Surgery at the Medical University of Vienna are enrolled into our study. Primary endpoint is the outcome (improvement of ODS symptoms), defined by ODS score.

Detailed description

Various surgical approaches for the treatment of obstructed defecation syndrome (ODS) commonly associated with rectocele and rectal intussusception have been investigated in the literature. Methods such as stapled transanal resection of the rectum (STARR) and ventral prosthesis rectopexy (VPR) show promising results at least in the short term. In the long-term, however, the results do not seem convincing. Schiano di Visconte et al. report a recurrence of ODS symptoms in 40 percent of the patients, treated with stapled transanal rectal resection in a 10-year follow up. The clinical outcome of surgical treatment of ODS using transanal minimally invasive surgery (TAMIS) in the sense of a mucosal resection without stapling technique has not yet been investigated. This project is designed to show the short-term outcome of non-stapled mucosal resection through TAMIS.

Conditions

Interventions

TypeNameDescription
PROCEDURETAMIS mucosectomyinternal Delorme's procedure using TAMIS

Timeline

Start date
2021-08-01
Primary completion
2023-10-01
Completion
2023-10-01
First posted
2024-07-26
Last updated
2024-07-26

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT06522399. Inclusion in this directory is not an endorsement.